Treatment of advanced thyroid cancer with targeted therapies: ten years of experience

  1. Rossella Elisei1
  1. 1Department of Clinical and Experimental Medicine, Section of Endocrinology, University of Pisa, Pisa, Italy
  2. 2Diagnostic and Interventional Radiology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy
  1. Correspondence should be addressed to R Elisei; Email: rossella.elisei{at}
  1. Figure 1

    Schematic representation of the two most important intracellular pathways, MAPK and PI3K/AKT, in thyroid cells.

  2. Figure 2

    Competitive ATP inhibition by TKIs at the catalytic binding site of RTKs.

| Table of Contents
Journal-based learning